Literature DB >> 27613556

Risk Stratification According to the Total Number of Factors That Meet the Indication Criteria for Radical Lymph Node Dissection in Patients with Early Gastric Cancer at Risk for Lymph Node Metastasis.

Katsutoshi Shoda1, Daisuke Ichikawa2, Tomohiro Arita1, Toshiyuki Kosuga1, Hirotaka Konishi1, Ryo Morimura1, Yasutoshi Murayama1, Shuhei Komatsu1, Atsushi Shiozaki1, Yoshiaki Kuriu1, Hisashi Ikoma1, Masayoshi Nakanishi1, Hitoshi Fujiwara1, Kazuma Okamoto1, Eigo Otsuji1.   

Abstract

BACKGROUND: Extended indications for endoscopic resection for early gastric cancer (EGC) have been widely accepted. However, according to current guidelines, additional gastrectomy with lymph node dissection (LND) is recommended for patients proven to have potential risks of lymph node metastasis (LNM) on histopathological findings. The aim of this study was to elucidate the risk stratification of outcome and LNM according to the number of factors that meet the inclusion criteria for radical LND for possible LNM (LNM risk factors) in patients with negative endoscopic resection margin.
METHODS: We enrolled 511 EGC patients whose tumors did not meet the absolute or extended indications for endoscopic resection, and investigated the risk stratification of prognosis and LNM according to the total number of LNM risk factors.
RESULTS: Recurrence-free and overall survival rates were significantly higher in patients with fewer LNM risk factors for surgical indication (p = 0.0274 and 0.0002, respectively; log-rank test), and the total number of LNM risk factors and frequency of LNM were significantly correlated (p < 0.0001; Kruskal-Wallis test). When only one LNM risk factor was satisfied, the LNM ratio was 0.58 % (1/173, 95 % confidence interval 0.01-3.18).
CONCLUSION: The present study suggested the possibility of using further minimally invasive treatment strategies based on the total number of LNM risk factors.

Entities:  

Mesh:

Year:  2016        PMID: 27613556     DOI: 10.1245/s10434-016-5553-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.

Authors:  Ryota Nakanishi; Eiji Oki; Hirofumi Hasuda; Eiki Sano; Yu Miyashita; Akihiro Sakai; Naomichi Koga; Naotaka Kuriyama; Kentaro Nonaka; Yoshiaki Fujimoto; Tomoko Jogo; Kentaro Hokonohara; Qingjiang Hu; Yuichi Hisamatsu; Koji Ando; Yasue Kimura; Tomoharu Yoshizumi; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2021-03-16       Impact factor: 5.344

2.  A Risk-Scoring Model for Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Retrospective Study and External Validation.

Authors:  Lihu Gu; Manman Chen; Parikshit Asutosh Khadaroo; Xueqiang Ma; Liya Kong; Xinlong Li; Hepan Zhu; Xin Zhong; Junhai Pan; XianFa Wang
Journal:  J Gastrointest Surg       Date:  2018-05-29       Impact factor: 3.452

3.  Assessment of Carbon Nanoparticle Suspension Lymphography-Guided Distal Gastrectomy for Gastric Cancer.

Authors:  Yuan Tian; Peigang Yang; Yecheng Lin; Yiyang Hu; Huiyan Deng; Wenqian Ma; Honghai Guo; Yang Liu; Ze Zhang; Pingan Ding; Yong Li; Liqiao Fan; Zhidong Zhang; Dong Wang; Qun Zhao
Journal:  JAMA Netw Open       Date:  2022-04-01

4.  Validity of additional surgical resection by comparing the operative risk with the stratified lymph node metastatic risk in patients with early gastric cancer after endoscopic submucosal dissection.

Authors:  Hidenori Akaike; Yoshihiko Kawaguchi; Kensuke Shiraishi; Hiroki Shimizu; Shinji Furuya; Naohiro Hosomura; Hidetake Amemiya; Hiromichi Kawaida; Makoto Sudoh; Shingo Inoue; Hiroshi Kohno; Daisuke Ichikawa
Journal:  World J Surg Oncol       Date:  2019-08-05       Impact factor: 2.754

5.  Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection.

Authors:  Lihu Gu; Mian Wang; Xuena Cui; Jiahang Mo; Lingling Yuan; Feiyan Mao; Kang Zhang; Derry Minyao Ng; Ping Chen; Dongjie Wang
Journal:  BMC Surg       Date:  2020-10-02       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.